NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

20.19

-1.06 (-4.99%)

At close: Oct 13, 2026, 4:00 PM EDT

20.20

+0.01 (0.05%)

After-hours: Oct 13, 2026, 7:30 PM EDT

NAMS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,413	3,978	2,751	920	889	139
Market Cap Growth	-42.16%	44.58%	199.19%	3.44%	537.58%	-
Enterprise Value	1,735	3,222	2,329	501	796	-
Last Close Price	20.19	35.08	25.70	11.17	10.90	9.75

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	338.92	176.77	60.38	65.26	8.66	-
PB Ratio	3.76	5.82	3.63	3.19	2.07	2.46
P/TBV Ratio	3.82	5.82	3.64	3.19	2.07	2.46
P/FCF Ratio	-	-	-	-	85.12	-
P/OCF Ratio	-	-	-	-	83.36	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	243.68	143.18	51.12	35.56	7.75	-
EV/FCF Ratio	-	-	-	-	76.18	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0	0	0.00	0	0	0.00
Debt / FCF Ratio	-	-	-	-	0.01	-
Net Debt / Equity Ratio	-1.07	-1.07	-1.10	-1.18	-1.09	-1.06
Net Debt / EBITDA Ratio	2.78	3.23	4.73	1.86	131.79	1.72
Net Debt / FCF Ratio	4.72	4.92	5.24	2.41	-44.77	2.04
Asset Turnover	0.01	0.03	0.08	0.03	0.38	-
Quick Ratio	8.76	7.69	8.00	6.86	13.03	5.81
Current Ratio	9.03	7.88	8.07	6.95	13.26	5.96
Return on Equity (ROE)	-36.81%	-28.29%	-46.20%	-49.25%	-9.30%	-159.01%
Return on Assets (ROA)	-20.11%	-17.27%	-18.19%	-27.70%	-0.81%	-55.71%
Return on Capital Employed (ROCE)	-38.70%	-33.00%	-23.30%	-61.60%	-0.80%	-61.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-10.75%	-5.12%	-8.78%	-19.24%	-2.55%	-29.97%
FCF Yield	-5.96%	-3.72%	-5.79%	-15.36%	1.18%	-21.18%
Buyback Yield / Dilution	-12.87%	-25.50%	-14.84%	-333.20%	-72.75%	-119.58%

SEC Filings: 10-K · 10-Q